Therapeutic effect of everolimus (RAD001) in combination with antiangiogenic chemotherapy for gastric cancer in vivo

被引：1
|
作者：
Cejka, D.
Preusser, M.
Sieghart, W.
Strommer, S.
Werzowa, J.
Fuereder, T.
Wacheck, V.
机构：
[1] Med Univ Vienna, Div Expt Oncol On, Vienna, Austria
[2] Med Univ Vienna, Inst Neurol, Vienna, Austria
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70075-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
69
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [31] The mTOR inhibitor RAD001 (everolimus) is active against multiple myeloma cells in vitro and in vivo
    Mitsiades, N
    McMullan, C
    Poulaki, V
    Negri, J
    Raje, N
    Kumar, S
    Sikoutri, D
    Hideshima, T
    Chauhan, D
    Richardson, PG
    Schlossman, RL
    Kung, AL
    Lane, H
    Munshi, NC
    Anderson, KC
    Mitsiades, CS
    BLOOD, 2004, 104 (11) : 418A - 418A
  • [32] THE COMBINATION EVEROLIMUS (RAD001) PLUS SORAFENIB IS SUPERIOR TO SORAFENIB MONOTHERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    Piguet, A. -C.
    Radojevic, V.
    Afthinos, M.
    Hora, C.
    Ledermann, M.
    Saar, B.
    Dufour, J. -F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S199 - S199
  • [33] RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid
    Morgan, T. M.
    Brown, L. G.
    Pitts, T. E. M.
    Gross, T. S.
    Vessella, R. L.
    Corey, E.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 36 - 37
  • [34] RAD001 (everolimus) induces autophagy in acute lymphoblastic leukemia
    Crazzolara, Roman
    Bradstock, Kenneth F.
    Bendall, Linda J.
    AUTOPHAGY, 2009, 5 (05) : 727 - 728
  • [35] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Chan, Jennifer A.
    Mayer, Robert J.
    Jackson, Nadine
    Malinowski, Paige
    Regan, Eileen
    Kulke, Matthew H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1241 - 1246
  • [36] Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
    Soria, J. -C.
    Shepherd, F. A.
    Douillard, J. -Y.
    Wolf, J.
    Giaccone, G.
    Crino, L.
    Cappuzzo, F.
    Sharma, S.
    Gross, S. H.
    Dimitrijevic, S.
    Di Scala, L.
    Gardner, H.
    Nogova, L.
    Papadimitrakopoulou, V.
    ANNALS OF ONCOLOGY, 2009, 20 (10) : 1674 - 1681
  • [37] RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid
    Morgan, Todd M.
    Pitts, Tiffany E. M.
    Gross, Ted S.
    Poliachik, Sandra L.
    Vessella, Robert L.
    Corey, Eva
    PROSTATE, 2008, 68 (08): : 861 - 871
  • [38] Effects of the combination of RAD001 and docetaxel on breast cancer stem cells
    Zhang, Xiaobei
    Zhang, Sheng
    Liu, Yan
    Liu, Jingjing
    Ma, Yi
    Zhu, Yuanxi
    Zhang, Jin
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1581 - 1592
  • [39] Preclinical studies of the combination of RAD001 with tamoxifen or letrozole in breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 142 - 142
  • [40] Effect of Everolimus (RAD001) on Acute Graft-Versus-Host Disease in Mice
    Kim, Dae Seong
    Park, Yoo Jin
    Lee, Myoung Woo
    Park, Hyun Jin
    Jung, Hye Lim
    Sung, Ki Woong
    Koo, Hong Hoe
    Yoo, Keon Hee
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (08) : 663 - 664
12345